Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials

Khwaja, Sadie, Kumar, Balasubrahmanyam, Philpott, Carl and Strachan, David P. (2019) Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. UNSPECIFIED.

Full text not available from this repository. (Request a copy)
Item Type: Other
Faculty \ School: Faculty of Medicine and Health Sciences > Norwich Medical School
Depositing User: LivePure Connector
Date Deposited: 19 Dec 2019 04:22
Last Modified: 22 Apr 2020 11:32
URI: https://ueaeprints.uea.ac.uk/id/eprint/73402
DOI: 10.1016/S0140-6736(19)31881-1

Actions (login required)

View Item View Item